汉森制药

- 002412

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
汉森制药(002412) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入26,928.66100,446.9569,398.1748,044.5825,403.25
营业收入26,928.66100,446.9569,398.1748,044.5825,403.25
二、营业总成本20,137.0477,258.6455,472.2337,997.6919,371.58
营业成本6,304.1524,253.0917,256.2812,199.136,544.56
营业税金及附加443.412,004.761,396.40958.10520.60
销售费用10,523.3440,031.6329,441.1120,075.6710,255.37
管理费用1,907.996,880.084,511.992,759.561,221.39
财务费用25.13156.86121.1391.8241.07
研发费用933.023,932.232,745.341,913.43788.59
资产减值损失----------
公允价值变动收益50.19207.36139.6980.8036.92
投资收益-4,527.96997.24474.021,181.01458.70
其中:对联营企业和合营企业的投资收益-4,671.55733.82278.631,053.32399.97
汇兑收益----------
三、营业利润2,253.2425,318.3614,971.5011,580.726,801.06
加:营业外收入5.0783.5845.2532.253.37
减:营业外支出47.35126.2861.2326.2310.72
其中:非流动资产处置损失----------
四、利润总额2,210.9625,275.6614,955.5311,586.736,793.71
减:所得税费用1,085.243,251.221,880.221,537.33967.25
五、净利润1,125.7222,024.4413,075.3010,049.405,826.47
归属于母公司所有者的净利润1,125.7222,024.4413,075.3010,049.405,826.47
少数股东损益----------
六、每股收益
基本每股收益(元/股)0.02240.43770.25980.19970.1158
稀释每股收益(元/股)0.02240.43770.25980.19970.1158
七、其他综合收益-2,133.732,010.87749.021,406.81613.39
八、综合收益总额-1,008.0124,035.3113,824.3211,456.216,439.85
归属于母公司所有者的综合收益总额-1,008.0124,035.3113,824.3211,456.216,439.85
归属于少数股东的综合收益总额----------
下载全部历史数据到excel中 返回页顶